![]() |
![]() February 2000 | ![]() |
IN THIS ISSUE:
ISB Receives Science Magazine Commendation
Global Treaty Adopted on Genetically Modified
EPA Restrictions on Bt Corn Announced
$180 Million Dedicated to USDA Projects
Roger Beachy Named R&D's "Scientist of the Year"
Attacks on GE Research Facilities Heat Up
A Sweeter Deal Than Expected from Transgenic Sugar Beets
Tandem Constructs for Superweed Prevention
New Troubles for Bt Corn?
In Search of Horizontal Gene Transfer
Production of Foreign Protein in Seminal Fluid
GM Product Labeling Caters Food for Thought

ISB RECEIVES SCIENCE MAGAZINE COMMENDATION
A short article in the December 17, 1999 issue of Science magazine lauds the Information Systems for Biotechnology Web site as one that ". . . cuts through the hype over bioengineered foods" and ". . . strives for middle-of-the-road perspective." The article, featured in the NetWatch section of the highly acclaimed journal, describes the News Report as a standout feature of the site. It also cites the usefulness of the database of proposed field trials of GM crops, with additional mention made of the risk assessment section, workshop proceedings, and biosafety committee list found at the site. ISB gratefully acknowledges this recognition.

Montreal, 29 January 2000 - After five years of talks, ministers and
senior officials from over 130 governments have finalized a legally binding
agreement for protecting the environment from risks posed by the transboundary transport
of living modified organisms (LMOs) created by modern biotechnology.
Under the Cartagena Protocol on Biosafety, governments will signal whether
or not they are willing to accept imports of agricultural commodities that
include LMOs by communicating their decision to the world community via an
Internet-based Biosafety Clearing House. In addition, shipments of these commodities
that may contain LMOs are to be clearly labeled.
Stricter Advanced Informed Agreement procedures will apply to seeds, live
fish, and other LMOs that are to be intentionally introduced into the environment.
In these cases, the exporter must provide detailed information to each
importing country in advance of the first shipment, and the importer must then authorize
the shipment. The aim is to ensure that recipient countries have both the
opportunity and the capacity to assess risks involving the products of modern biotechnology.
"This agreement goes a long way towards meeting the environmental
concerns of the international community," said Klaus Toepfer, Executive Director of
the United Nations Environment Programme (UNEP), which administers the secretariat of
the Convention on Biological Diversity, under whose auspices the talks took place.
One of the most contentious issues that negotiators had to
resolve involved the relationship between the Protocol and other
international agreements, notably those under the World Trade
Organization. While environmental agreements are premised on the
precautionary principle, decisions under trade law require
"sufficient scientific evidence." Under the new agreement, the Protocol and
the WTO are to be mutually supportive; at the same time, the
Protocol is not to affect the rights and obligations of governments under
any existing international agreements.
The meeting was attended by over 700 delegates from
governments as well as from intergovernmental and non-governmental
organizations. Over 40 ministers attended during the final two
days.The agreed text of the Biosafety Protocol will be opened for signature
at UNEP headquarters in Nairobi from 15 - 26 May, on the occasion
of the Fifth Session of the Conference of the Parties to the
Convention on Biological Diversity (COP 5). The Protocol will then enter
into force for its members after 50 countries have ratified it.
Press Release
EPA RESTRICTIONS ON Bt CORN ANNOUNCED
In response to concerns that Bt corn may be accelerating
the evolution of pesticide resistant insects, the EPA has
announced new restrictions on GE corn cultivation. The new
restrictions, which became effective January 14th, require registrants to
ensure that growers plant a minimum of 20 percent of their acreage
in non-Bt corn refuges. For corn grown in cotton areas, the
non-Bt refuge requirement is increased to at least 50 percent. In
addition, registrants have been asked to expand monitoring for any
potential insect resistance and communicate any voluntary measures
taken to protect non-target insects, particularly the Monarch butterfly.
Response from the agriculture industry has been positive.
This statement was issued by the National Corn Growers
Association: "NCGA strongly supports the planting of [Insect
Resistance Management] refuges because they allow the maximum use
of this pest control technology while maintaining its long-term
effectiveness," said Fred Yoder, Plain City, Ohio, farmer and a
member of NCGA's Corn Board. "We welcome EPA's statement
because it generally follows the plan we submitted. The EPA's
announcement actually validates those recommendations." (See:
NCGA Welcomes EPA Biotech Decision. http://www.ncga.com/archives/news000115.html)
For more information on EPA's biotechnology regulatory
program for plant pesticides, see: http://www.epa.gov/pesticides/biopesticides
$180 MILLION DEDICATED TO USDA PROJECTS
Agriculture Secretary Dan Glickman unveiled plans
for $180 million in new USDA investments in projects aimed
at boosting the rural economy, promoting agricultural
research, and developing new agricultural products and practices
for the future.
Glickman awarded $60 million in Fund for Rural
America research and economic development grants. The
remaining $120 million will be distributed through a competitive
grant process under the Secretary's new Initiative for
Future Agriculture and Food Systems. The USDA will issue
a request for proposals to solicit specific project proposals
for the Initiative later this year. The Initiative will fund
competitive research, education, and extension grants that focus
on production agriculture, natural resource management,
and consumer issues.
The Initiative's priorities include:
See: http://www.usda.gov/news/releases/2000/01/0007
ROGER BEACHY NAMED R&D'S "SCIENTIST OF THE YEAR"
Roger Beachy, President of the Donald Danforth
Plant Science Center in St. Louis, was selected by R&D
magazine as "1999 Scientist of the Year" for his
technology transfer achievements in plant genetics. R&D Magazine
is a monthly trade journal serving commercial and
governmental research and development scientists. Beachy
has extensive academic and industrial experience in
plant genetics and plant pathology and is credited with
developing one of the earliest GM crops, a virus-resistant tomato, in
a cooperative project with Monsanto. Much of
Beachy's GMO work is aimed at agricultural technology transfer,
and he is commended for his achievements in the
commercialization of promising genetic technologies and products.
Beachy is most noted for his innovative GMO
advances intended for use in developing nations. He is a
strong proponent of using transgenic plants carrying
pesticidal traits and herbicide resistant genes, which he views as
a safe and environmentally sound technology for
increasing crop yield in developing countries. The November
R&D article about Beachy's award is available online at
http://www.rdmag.com.
Brian R. Shmaefsky
ATTACKS ON GE RESEARCH FACILITIES HEAT UP
A deliberately set fire has damaged the offices of
the Agricultural Biotechnology Support Project (ABSP)
based in Agriculture Hall at Michigan State University
(MSU). The office of Catherine Ives, Director of ABSP
and visiting professor at MSU, was the alleged target of
the December 31, 1999 fire. An underground activist
group known as the Earth Liberation Front (ELF) claimed
credit for the property damage. The fire is currently
under investigation by authorities including the Bureau of
Alcohol, Tobacco, and Firearms, and Federal Bureau of
Investigation. The press reported the damage estimate at
approximately $400,000; however, "That's not official and
is probably an underestimate," says
Ives1.
The stated goals of the ELF organization are to "End
GE!" and " . . . stop the systematic exploitation and destruction
of the natural environment," according to a News
Advisory posted on an Internet listserver maintained by the
Bioengineering Action Network2. Actually, ELF only managed to
set back progress on the USAID-funded project, which
has been ongoing since 1991, by about a month. According
to Ives, "Almost all the data was retrievable and we're back
in business as usual in other offices."
In a communiqué issued by ELF and distributed by
spokesperson Craig Rosebraugh, the group claimed Ives's
offices were targeted in part because the ABSP project is funded
by Monsanto and USAID. The communiqué states:
"On the eve of the new millenium [sic], the ELF struck
back at one of the many threats to the natural world as we
know it. On December 31, 1999 at approximately
9:00 pm, the ELF entered the Agricultural Hall at
MSU in Lansing, Michigan. Our destination was room 324, the offices
of Catherine Ives et al. The project being conducted
through this office is funded by Monsanto and USAID and
was designed to not only pursue research concerning
genetically engineered sweet potatoes, corn and other crop
vegetables, but to lobby developing countries to abandon their
current agricultural practices and to rely on genetically
engineered plants and thus corporations like
Monsanto"3.
In fact, "We aren't funded by Monsanto," responds
Ives. Of the approximately $20.8 million in funding the
project has received over its life, 87.7% was from USAID and
the rest obtained from matching MSU and private sector
funds, and small grants. However, Monsanto is credited
with giving the project a one-time sum of $2000 in
travel moneynot much, relative to $20.8 million, but
enough, apparently, to incite the ire of ELF.
Ives also firmly rejects the claim that the USAID
project encourages developing countries to ". . . abandon
their current agricultural practices . . . ." Ives responds, "We
do no such thingwe educate and train people in the use
of molecular tools and the important regulatory issues
that surround their safe and legal deployment. We
recognize that biotechnology must be integrated into
conventional, traditional systems. USAID is involved in the
development and transfer of technologies that can assist in
poverty alleviation, improved health, and promotion of a
sustainable environment"1.
The attack at the MSU campus is not an isolated
incident; although, given the potential for loss of life, it is one of
the most disturbing to date. Most anti-GE activists' actions
have focused on the destruction of GE crops, primarily
at research sites. For example, on January
20th of this year, members of the Fragaria Freedom Fighters group
claimed responsibility for the destruction of a field of
genetically modified strawberries at Plant Sciences Inc.
research facilities in California4. According to a statement released
by the GenetiX Snowball Press Office, "This action is the
21st known action taken against genetically engineered crops
and multinational biotechnology corporations in the last
year"5.
Catherine Ives suggests researchers take a common
sense approach to protect research facilities from similar
attacks. She said they have been told to maintain a general
vigilance, keep doors locked, and be on the look out for strangers
who don't seem to have a reason for being in the area.
"And above all, back up all data from your hard drive on a
regular basis and keep copies in separate locations," stressed
Ives. She added that if they had stored important papers, such
as passports and supporting documents for their foreign staff,
in a fire proof safe, many hassles would have been avoided.
Sources
1. Ives C. Pers. Comm. January 26, 2000. Ivesc@msu.edu
2. Bioengineering Action Network of North America.
http://www.tao.ca/~ban (January 27, 2000)
3. BAN Listerver. ban@lists.tao.ca
4. Bioengineering Action Network of North America.
http://www.tao.ca/~ban/100ARwatsonville.htm
5. King, Dylan. GenetiX Alert Press Office.
galert@angelfire.com. GenetiX snowball. http://www.gn.apc.org/pmhp/gs/ (January 27, 2000)
Ruth Irwin
A SWEETER DEAL THAN EXPECTED FROM TRANSGENIC SUGAR BEETS
The technical feasibility of producing novel products
in traditional crops has been demonstrated many times, but
in very few cases have these discoveries been put
into commercial use. This is due to a number of factors,
largely economic in nature. Few transgenic plants produce
the compound of interest at a high enough level to offset
the cost of processing, and in many cases the
infrastructure necessary for processing the novel product simply does
not exist. Now, recent experiments describing fructan
production in transgenic sugar beet seem to satisfy all the
demands for commercial production along with the possible
side benefit of enhanced agronomic performance under
conditions of drought stress.
Fructans are fructose polymers of commercial interest
due to their promise as replacements for high calorie
sweeteners and fats. Short chain fructans have the same
sweet taste as sucrose, but provide no calories as humans lack
the fructan-degrading enzymes necessary to digest them.
The same is true for the longer chain fructans, which
form emulsions having fat-like textures. Humans may not be
able to utilize fructans, but the natural bacterial flora of
the human gut can, resulting in a stimulation of their growth
and leading to an increase in overall digestive health.
Currently, commercial production of small fructans
from sucrose is carried out enzymatically in bioreacters using
a fructosyl transferase isolated from Aspergillus
niger. This production method is extremely expensive, resulting in
a final cost for the compound that is too high for use
in general foodstuffs. However, fructans accumulate
naturally in about 15% of flowering plant species, including a
number of traditional crop species such as wheat, onion, chicory,
and Jerusalem artichoke, where they function primarily as
a storage carbohydrate. The latter two species have
been used for commercial extraction of fructans, but poor
yield and complications with processing and product quality
have ultimately rendered both plants economically unfeasible
as sources.
Part of the problem with using natural sources for
fructan extraction lies in the enzymes that control the synthesis
and accumulation of these molecules. In plants, fructan
synthesis occurs in the vacuole and begins with the conversion
of sucrose to short fructose polymers through the action of
1-sucrose:sucrose fructosyl transferase (1-SST). A
second enzyme, 1-fructan:fructan fructosyl transferase (1-FFT),
is responsible for producing the longer chain forms of
fructan by transferring fructosyl residues from one fructan
molecule to another or to sucrose.
The combined action of these two enzymes results in a
mix of fructans of different lengths, and additional
enzymes cause branching or hydrolyze the chains to varying
degrees. This mix of fructan end products causes problems
for commercial manufacturers because a fairly
homogeneous product is desirable. Consequently, additional processing
is often necessary with fructans obtained from
endogenous sources, driving up the cost of production.
With the cloning of cDNAs for 1-FFT and 1-SST from
plant and bacterial sources, interest has grown in
introducing these enzymes into plant backgrounds that do not
normally synthesize fructans. The rationale behind this is that
by introducing a single fructosyl transferase into a plant
species devoid of fructan biosynthetic enzymes, it should be
possible to produce a particular class of fructan molecules.
The feasibility of this approach has been demonstrated by
the introduction of fructosyl transferases from both
bacterial and plant sources into tobacco, corn, and potato
plants. However, in all these cases, the levels of fructan
produced were not high enough to be economically useful or
had deleterious effects on plant growth and development.
All photosynthetic plants synthesize sucrose, so any
crop plant potentially could be engineered to produce
fructan. However, sugar beet has several features that make it
a logical choice. Sugar beet is bred to produce and store
large amounts of sucrose, the precursor of fructan, and
the majority of the sugar produced is stored in taproot
cell vacuoles, the site of fructan synthesis. From a
processing standpoint, the infrastructure already exists to extract
and purify sugar compounds from beets. On the other
hand, sugar beets are notoriously difficult to transform, a
feature that has dissuaded a number of researchers from
working with this species. In an article in Nature Biotechnology, Koops and
his colleagues described how they were able to overcome
this hurdle by creating a transgenic line of sugar beet in
which 40% of the taproot dry weight was converted to short
chain fructans without discernible impact on plant growth
or phenotype1. They utilized a stomatal guard
cell-based method of transformation to introduce a construct
containing a cDNA encoding 1-SST from Jerusalem
artichoke. After regeneration of intact plants, eight
independently transformed lines were recovered and demonstrated
to contain between one and greater than eight copies of
the transgene. Biochemical analysis confirmed that the
inserted gene was expressed and functional in six of the eight
lines. To verify that the plants were producing fructans,
Koops and his colleagues performed both thin layer
chromatography and high pressure anion exchange chromatography
on extracts from taproot, the site of maximal sucrose
production in wild type plants. They found that over 90% of
the endogenous sucrose had been converted to small
fructan molecules when compared with wild type lines, resulting
in a yield of 110 µmol/g fresh weight. This impressive yield
has led the authors to refer to their transgenic plants as
"fructan beets" instead of sugar beets.
In a recent paper in Plant Physiology and
Biochemistry, Pilon-Smits and her colleagues described a related set
of experiments that point to a possible added
agronomic benefit of these plants2. They also created
fructan-producing sugar beets, this time using a bacterial fructosyl
transferase instead of a plant fructosyl transferase. This
enzyme, SacB, obtained from Bacillus
subtilis, successfully catalyzed the production of long chain fructans in the
transgenic plants. Though these plants displayed a relatively low
level of fructan accumulation (0.5% dry weight in the
highest-producing lines), they performed significantly better
under conditions of drought stress when compared to wild
type plants. Similar results were also reported previously
for tobacco transformed to express fructan. The discovery
of the drought tolerance benefit is not surprising as it has
long been suggested that fructans of all lengths have a role
in defending plants against drought stress in species
that naturally accumulate these compounds. However, in
most cases, it has been difficult to correlate increased levels
of fructans with drought tolerance.
With this in mind, it will be interesting to establish
whether the "fructan beets" created by Koops and co-workers
will display an increase in drought tolerance to accompany
their altered biochemical makeup. If not, the findings by
Pilon-Smits may provide important insights into the
chemical requirements of fructan-mediated drought tolerance.
Either way, it seems that transgenic sugar beet may hold
the promise of finally making useful compounds such
as fructans more economically available.
Sources
1. Sevenier R, Hall RD, van der Meer IM, Hakkert HJC,
van Tunen AJ, and Koops AJ. 1998. High level fructan
accumulation in transgenic sugar beet. Nature
Biotechnology 16:843-846
2. Pilon-Smits EAH, Terry N, Sears T, and van Dun K.
1999. Enhanced drought resistance in fructan-producing sugar
beet. Plant Physiology and Biochemistry 37:313-317
Claire Granger
TANDEM CONSTRUCTS FOR SUPERWEED PREVENTION
Jonathan Gressel, of the Weizman Institute of Sciences
in Israel, is well aware of one nightmare no farmer wants
to encounter; he knows the bane of treating a field
containing weeds not controllable with any available
herbicide. Gessel's most recent paper, "Tandem constructs:
Preventing the rise of superweeds," published in
Trends in Biotechnology, brings some hope to prevention of
superweed evolution1.
Gressel is a vocal proponent of plant biotechnology,
yet much of his research assails a large biotechnology
marketherbicide resistant crops. His argument, however,
is not for limiting biotechnology, but instead for
encouraging responsible biotechnology geared to make GMOs
safe. Continuous herbicide use may lead to artificial selection
of herbicide resistant weeds due to the reproductive
advantage conferred on weeds possessing natural
herbicide resistant genes. Studies show that many weed plants in
the natural population contain these
traits2,3.
Encouragement of superweed evolution by
artificial selection is not the only argument leveled against
using herbicide resistant crops. Gressel also is concerned
that, "Transgenic crops may interbreed with nearby weeds,"
an opinion based on studies going back to 1986
suggesting transgenic traits can be horizontally transferred to
wild relatives of domesticated plants. Scottish researchers
were alerted to horizontal gene transmission following
several field trials conducted in 1996 showing that pollen
from genetically engineered rape traveled over 2.5
kilometers and fertilized other rape plants. The rape plant used in
the study was developed for herbicide resistance.
Population genetics studies conducted recently on cultivated and
wild beet plants indicate the potential for this transfer
between genetically engineered plants and weed relatives
(see "Gene Flow Between Cultivated and Wild Beet,"
ISB News Report, December 1999.)
Some groups use evidence of horizontal gene transfer
as grounds to protest the continued cultivation of
transgenic crops. They argue that wild plant populations are
being "genetically polluted" with traits not normally found in
the population, and that may harm wild populations by
causing extinction of the species, development of pest
resistant plants, loss of economically useful alleles, and
emergence of wild weed populations resistant to standard
chemical control methods.
Gressel criticizes GMO risk analyses that ignore the
utility of GE technology designed to prevent gene transfer.
He postulates that gene transfer could be prevented in part
by using tandem constructs; that is, the piggybacking of
genes that affect germination by altering seed dormancy,
ripening, and dissemination with genes for the desired trait in the
construct. Other strategies include adding traits that cause
dwarfing, inhibit flower production, prevent maturation, or
induce pollen sterility. For example, an antibolting trait would
work well to prevent the transmission of genes in biennials
such as cabbage. Gressel notes that tandem constructs can
also be used for further development of crops carrying traits
for insect resistance and enhanced nutritional value.
Gressel supports using tandem constructs for what he
coins "Transgenic Mitigation" because they: 1) are tightly
linked and do not segregate separately; 2) use traits that
are harmless to crops but deleterious to typical weeds; and
3) are disadvantageous to the successful reproduction
of weeds within a population lacking the construct
trait1,3. Gressel notes that many of the traits that are suitable
as useful constructs are already mapped for numerous
plants and can simply be attached to the desirable traits
already engineered into crops.
Sources
1. Gressel J. 1999. Tandem constructs: Preventing the rise
of superweeds. Trends in Biotechnology 17(9): 361-366.
2. Gressel J. 1988. Multiple resistances to wheat
selective herbicides: New challenges to molecular biology.
Oxford Surveys of Plant Molecular and Cell
Biology 5:195-203.
3. Gressel J, Gardner S, and Mangel M. 1996. Prevention
vs. remediation in resistance management. In Molecular
Genetics and Ecology of Pesticide Resistance, ed. TM Brown.
Washington, D.C.: American Chemical Society.
Brian R. Shmaefsky
NEW TROUBLES FOR Bt CORN?
A study reported in December in the journal
Nature seems poised to add fuel to the fiery debate over the
possible environmental impact of Bt corn. In a brief
communication to the journal, Guenther Stotzky and his colleagues
report preliminary findings from a study indicating that
root exudates from Bt corn contain biologically active Bt
toxin and that the toxin retains its activity long after its
release from the plant1.
There is increasing concern about the
environmental impact of widespread cultivation of corn varieties
engineered to constitutively express the insecticidal proteins
of Bacillus thuringiensis. This is due largely to the
publication of an article earlier this year, also in the journal
Nature, that described how larvae of the Monarch butterfly
were killed after feeding on milkweed leaves dusted with Bt
corn pollen. The validity and relevance of this study has
been hotly debated, but it has clearly stimulated greater
interest in tracking the spread and persistence of Bt toxin in
the environment as the result of the cultivation of these
corn varieties.
Previous work by Dr. Stotzky and colleagues at New
York University demonstrated that toxins from two
separate strains of Bacillus thuringiensis are capable of
persisting when introduced into a variety of soil types. By mixing
Bt toxins with soils or soil components, they determined
that the toxins bind to clays or humic acids in soils, and
this binding process protects these compounds from
microbial degradation, at least in a laboratory
setting2. They also found that the insecticidal activity of the toxins, as
determined by bioassay, was not affected by being bound to
the soil particles. In fact, in a couple of cases the
insecticidal activity of the toxin increased after
binding3. However, the stability of the toxin's insecticidal activity varied
widely, depending largely on the properties of the soils used in
the experiments. Soils with more neutral pH values displayed
a significant decrease in toxin activity within as little as
14 days, whereas soils with a more acidic pH value
retained insecticidal activity for as long as six months.
In their latest study, described in
Nature, Stotzky and co-authors reported finding biologically active Bt toxin
that was released from the roots of Bt corn into growth
medium and the soil environment. When Bt corn was grown
in sterile liquid medium, the presence of Bt toxin was
detected in the medium by performing a commercial
immunological assay and an insecticidal bioassay on
tobacco hornworm larvae.
No such protein was found when the growth medium
from the corresponding non-Bt corn variety was analyzed.
When similar tests were performed on soil samples
surrounding the rhizosphere of Bt corn seedlings, they found similar
Bt toxin activity, which persisted in the soil for at least
25 days. They concluded that the toxin may accumulate in
soil under continuous cultivation of Bt corn and suggested
that this accumulation may lead to unanticipated impacts
on non-target organisms in the soil.
At least one anti-biotechnology group is already using
the results from this paper as evidence of the potential for
Bt corn to create widespread environmental
damage4. However, this article describes results that are preliminary
at best, and, in the absence of hard data, it is difficult to
draw definitive conclusions from this work. Ultimately,
determining the impact, if any, of Bt corn on soil fertility will
require additional and far more extensive research under
field conditions before verifiable conclusions can be reached.
Sources
1. Saxena D, Flores S, and Stotzky G. 1999. Insecticidal toxin
in root exudates from Bt corn. Nature 402:480.
2. Crecchio C and Stotzky G. 1998. Insecticidal activity
and biodegradation of the toxin from Bacillus
thuringiensis subsp. kuristaki bound to humic acids from soil.
Soil Biology and Biochemistry 30:463-470.
3. Tapp H and Stotzky G. 1998. Persistence of the
insecticidal toxin from Bacillus
thuringiensis subsp. kuristaki in soil.
Soil Biology and Biochemistry 30:471-476.
4. Anonymous. 1999. GE crops with Bacillus
thuringiensis (Bt) genes suspected to harm soil ecology. Physicians and
Scientists for Responsible Application of Science and Technology.
http://www.psrast.org/btsoilecol.htm
Claire Granger
IN SEARCH OF HORIZONTAL GENE TRANSFER
"Critics of agricultural biotechnology have often
been dismissed as modern-day Luddites," proclaims
Michael Syvanen in his commentary published in Nature
Biotechnology1. Syvanen, a professor of medical microbiology
and immunology at the University of California, Davis,
defends the concerns of biotechnology opponents in his article
titled, "In search of horizontal gene transfer." His commentary
is offered in response to assertions made by several
researchers and the US Food and Drug Administration (FDA)
that horizontal gene transfer from plants to bacteria is
not feasible. The FDA comment was referring to plant
cells carrying antibiotic-resistance genes added to assist with
the identification of transformed cells. These cells are
eventually cultured into adult plants and released into the field.
The impact of horizontal gene transfer concerns
agricultural biotechnology critics who claim that novel genes
inserted into domesticated organisms might be transferred to
wild organisms_an example would be the transfer of
antibiotic resistance marker genes to soil bacteria. Studies
supporting this argument are based on in vitro experiments,
comparative gene frequency studies, and investigations of
reproductive strategies2.
Syvanen's studies of bacterial and plant phylogeny
indicate horizontal gene transfer is involved in evolutionary
change. His work consists of numerous genetic studies dating
back to the early 1980's, including recent genomic
investigations on Archaea. Other researchers have reported evidence
that functional chunks of DNA persist in the environment,
and that significant quantities of plasmid DNA survived
passage through a mouse digestive system and even stayed
intact after macrophage ingestion. Although Syvanen
concedes there are no confirmed studies of this type of gene
transmission occurring in nature, he cautions that laboratory
studies are evidence enough to warrant concern.
A disturbing consequence of horizontal gene transfer
in bacteria is the potential for antibiotic resistance and
other traits carried on plasmids to migrate from one type
of bacterium to another. Evidence suggests genomic DNA
is transmitted in nature. In bacteria, conjugation is the
most likely mechanism responsible for gene transfer.
Also, evidence of transfer of genetic material between
unrelated prokaryotes and between Archaea and prokaryotes early
in the evolution of prokaryotes may be explained by
conjugation and the uptake of environmental DNA. In the introduction
to Horizontal Gene Transfer, a book co-authored by
Syvanen and Clarence Kado, reference is made to
experimental evidence for plasmid transfer between
E. coli and actinomycetes,
Agrobacterium, and
cyanobacteria2. The rapid diversification of eucaryotic evolution may have
been accompanied by extensive gene transfer.
The possibility that gene transfer occurs between
distantly related organisms such as bacteria and plants, or animals
and plants, is the subject of speculation and debate. The
most extensively studied mechanism of gene transfer
from bacteria to plants is found in
Agrobacterium, which readily transmits a plasmid that induces tumor development
when incorporated into plants. Laboratory studies show that
the bacteria are capable of transcribing and translating
plant genes as well2.
Transposon-like elements are likely vehicles for cutting
and pasting genomic DNA from one organism to
another. Jeffrey Palmer of Indiana University suggests that a
genetic parasite resembling a transposon can carry or "jump"
a segment of yeast DNA into higher plants. Clarence Kado,
a plant pathologist who has collaborated with Syvanen,
believes viruses may be responsible for transmitting genes
between eucaryotes. Also, a few scientists suspect that viral
transmission of regulatory genes was involved in the
macroevolution of metazoa. It is also believed that viruses may
be responsible for the origin of introns in eucaryotic DNA.
In fact, the theory that viruses are responsible for
transmitting traits between unrelated organisms suggests that
horizontal gene transfer could be a common event.
Molecular evolution estimates indicate that horizontal
gene transmission is more likely to occur in microorganisms
and plants. However, animal studies also provide evidence of
the horizontal transmission of Drosophila P-elements.
Syvanen likewise believes that gene transfer is probable, though
not common, in humans and other animals.
Syvanen argues that some of the gene frequency
studies, such as those examining neomycin
phosphotransferase, provide weak evidence of the dangers of gene
transfer because, "This gene is already ubiquitous, so it is far
from clear that its presence in genetically engineered plants
will add substantially to the existing danger."
Though biotechnology opponents may use the implications from Syvanen's
work to justify limiting the employment of GMOs, Syvanen
himself does not condemn using GMOs in the field. He states,
"If horizontal transfer is found out to occur naturally, perhaps
the most significant outcome would be the reshaping of
our evolutionary paradigms." However, Syvanen does
argue, "If and when experiments prove that horizontal transfer
occurs, the implications will be debatable. In such a scenario,
some vectors might indeed create an unacceptable risk."
Sources
1. Syvanen M. 1999. In search of horizontal gene transfer.
Nature Biotechnology, 17(9): 833.
2. Syvanen M and Kado CI. 1998. Horizontal gene
transfer. London: Chapman & Hall.
3. Syvanen M. 1994. Horizontal gene transfer: Evidence
and possible consequences. Annual Review of Genetics
28:237-261.
Brian R. Shmaefsky
PRODUCTION OF FOREIGN PROTEIN IN SEMINAL FLUID
Transgenic animals are being developed as bioreactors
for the production of important pharmaceutical proteins.
The mammary gland is generally considered to be the tissue
of choice because large volumes of milk can be easily
collected. However, the production of milk-derived proteins
is limited by the relatively long time interval from birth to
first lactation and the discontinuous nature of the lactation
cycle. Furthermore, the presence of casein micelles and
fat globules in milk can complicate protein purification
procedures. Therefore, alternative bodily fluids such as blood
and urine have been explored as potential sites for foreign
protein production.
In the November 1999 issue of Nature
Biotechnology, researchers at the University of Laval in Quebec report
the production of human growth hormone (hGH) in the
seminal fluid of transgenic mice. Seminal fluid represents a
promising alternative for the production of pharmaceutical
proteins because it can be collected non-invasively and is available
on a continuous basis.
In the article, the authors report that a hGH gene was
fused to the promoter of a mouse protease inhibitor gene that
is expressed in the accessory sex glands. This construct
was used to produce four transgenic founder mice, three
males and one female. Two of the founder males that
secreted detectable levels of hGH in their seminal fluid and passed
the transgene on to their progeny were further examined.
Expression of hGH was assayed in a number of
different tissues of the transgenic mice. As expected, hGH
mRNA and protein were detected in the seminal vesicles.
However, unexpected expression of hGH was observed in the
kidney. In addition, no pancreatic expression of hGH was
detected although this protease inhibitor gene is reported to
be constitutively expressed in this tissue.
The concentration of hGH in seminal fluid was measured
for the two lines derived from the transgenic founder
males. One male contained 240 µg/ml hGH in
preejaculatory seminal fluid present within the seminal vesicle, while
the other male contained 470 µg/ml. These concentrations
of hGH represent 0.24 to 0.72% of the total protein in
the seminal fluid. The level of hGH in ejaculates as measured
by vaginal plug extracts was much lower, one to three
µg/ml. However, the vaginal plug extract may not serve as
an accurate assay of the true levels of hGH in seminal fluid.
Circulating concentrations of hGH were substantial
and probably resulted from ectopic expression in the
kidney. Samples from the blood of twelve week old male and
female mice contained between 250 and 500 ng/ml hGH.
These elevated levels of hGH resulted in a 23 to 77% increase
in 12-week old body weights compared with
non-transgenic mice.
This technology can now be applied to the production
of transgenic pigs. Pigs are the species of choice because
a boar ejaculates the largest volume of seminal fluid of
all domestic livestock, averaging about 250 ml, reaches
sexual maturity at 110-125 days of age, and can ejaculate two
to three times per week year round. Assuming a
production level of 0.5 µg/ml and two ejaculations of 250 ml per week,
a single transgenic pig could produce 13 grams of protein
per year.
These results demonstrate the potential for using
seminal fluid as a target for foreign protein production. The
side effects resulting from ectopic expression of the
foreign protein, however, are an issue that still needs to be
addressed. Nevertheless this report adds accessory sex glands to the
list of previously reported tissuesmammary gland, blood,
and bladderwhich may be used as potential bioreactors.
Source
Dyck MK, et al. 1999. Seminal vesicle production and
secretion of growth hormone into seminal fluid.
Nature Biotechnology 17: 1087-1090.
Eric A. Wong
GM PRODUCT LABELING CATERS FOOD FOR THOUGHT
For good reason, Science magazine has designated
the debate over genetically modified (GM) foods as the
"controversy of the year." Throughout the world, there have
been numerous manifestations of the backlash against GM
crops and food derived from GM crops. The European
Union (EU), for example, has decided to suspend the introduction
of new GM crops pending legislation, which may take
three years to resolve. Meanwhile, Japan's health ministry
recently announced that it would not approve any more GM
foods, pending the introduction of tighter regulations next
April. Even Monsanto's caterer for the United Kingdom
headquarters banned GM food from the staff cafeteria. In the
United States, the summer and fall of 1999 saw an intensification
of protests, including the damage of private and
university research plots.
One position that various governments have adopted is
that GM crops and food allowed in the market must be labeled
as such. GM product labeling is required in Britain and
Switzerland, and is under EU regulations, while Japan and
South Korea plan to implement labeling requirements. At
present, there is no mandatory requirement for labeling GM
products in the US. This is a situation that activists are trying to
change using a number of justifications, including the
unsupported allegation that GM food is not safe. The issue of food
safety falls within the purview of the Food and Drug
Administration (FDA).
Labeling Safely
Under the Federal Food, Drug, and Cosmetic Act, the
FDA has the authority to ensure the safety and wholesomeness
of most foods, except meat and poultry. In 1992, the
FDA published a policy statement on the regulation of foods
and animal feeds derived from new plant varieties developed
by genetic engineering techniques. An evaluation of the
safety and nutritional composition of food derived from GM
plants relies upon information pertaining to the agronomic
and quality attributes of the plant, genetic analysis of the
modification and stability of expected genomic traits, evaluation of
the safety (i.e., toxicity and allergenicity) of any newly
introduced proteins, and chemical analysis of important toxicants
and nutrients. The FDA requires pre-market approval for
molecules (proteins, fatty acids, carbohydrates, etc.) produced
by introduced genes, if these molecules differ substantially
in structure and function from typical molecules found in foods.
A basic principle of the 1992 policy is that the FDA uses
a science-based approach for ensuring the safety of foods
from new plant varieties. The FDA focuses its evaluation on
the objective characteristics of the food or its components,
rather than the fact that new development methods were used,
at some point, to produce the food. Accordingly, the Agency
has not required labeling for other non-GM methods of
plant breeding, such as chemical-induced or
radiation-induced mutation, somaclonal variation, or cell culture.
Labeling Religiously
In May 1998, the Alliance for Bio-Integrity filed a
lawsuit against the FDA seeking to institute mandatory labeling of
all GM foods1. The suit alleged, among other things, that
current FDA policy violates the freedom of certain religions
that adhere to dietary laws. Anti-GM food activists often raise
this religion-based issue as a justification for labeling.
This argument, however, does not seem particularly
compelling. For example, both Orthodox Rabbis and Muslim leaders
have decided that simple gene additions, which lead to one or
a few new components in a species, are acceptable for
kosher and halal law2. Although animal-to-plant gene transfers
could cause concern for people adhering to certain dietary
restrictions, the FDA has pointed out that no such products are
yet marketed, and that the Agency would have the opportunity
to consider such a case if it arises.
The Vatican's Pontifical Academy for Life recently
announced its decision that modifying the genes of plant
and animals is theologically
acceptable3. Nevertheless, the vice-president of the Academy
stated that consumers must be informed about GM products through proper
labeling. This ill-defined "right to know" is another popular
justification for labeling.
Labeling Righteously
During November, the US House of Representatives
introduced H.R. 3377, a bill that would require the following
notice on foods derived from GM crops: "Genetically
engineered; United States government notice: This product
contains genetically engineered material, or was produced with
a genetically engineered material." The bill suggests
that qualifying food would contain as low as 0.10 percent
GM ingredients, a standard that is ten times more strict than
the EU requirement. Representative Dennis Kucinich
(D-OH), who co-sponsored the bill, explained, presumably
sincerely, that no one is suggesting that GM food is dangerous, but,
"If we are what we eat, then consumers must know what
they are eating." One of the doctrines of the legislation is that
the process of genetically engineering foods results in
the material change of such foods. This material change
seems to be one of perception, and not based on fact.
H.R. 3377 is subtitled "Genetically Engineered Food Right
to Know Act." Yet the Federal Food, Drug, and Cosmetic
Act does not require disclosure in labeling of information
solely based on the consumers' desire to know. According to
the FDA's interpretation of the Act, the agency does not
even have the authority to mandate labeling based solely upon
a consumer's right to know the method of production if the
final product is considered safe. And, despite the hoary
cliché, there simply is no overriding "right to know" principle.
A federal appellate court clearly made this point in
the International Dairy Foods Association
case4. Dairy manufacturers challenged the constitutionality of a
Vermont statute that required identification of products that were,
or might have been, derived from dairy cows treated
with recombinant bovine somatotropin. The appellate court
agreed with the dairy manufacturers that the labeling law
was contrary to the constitutional right not to speak. Moreover,
the court noted that Vermont defended the statute, not on
any health or safety concerns, but on the basis of the public's
right to know. The court found that consumer curiosity is
insufficient to justify compromising protected constitutional
rights, and the court noted that it was unaware of any case in
which consumer interest alone was sufficient to justify a
requirement that is the functional equivalent of a warning about
a production method that has no discernible impact on the
final product.
Labeling Voluntarily
Agriculture Secretary Glickman told Consumer
Reports, "Frankly, if the consumers demand labelingeven if we
think it doesn't convey a lot of good stuffwe're probably going
to end up with a labeling scheme"5. There have been
several reports that the USDA is advocating a labeling plan
intended to meet demands of the European market. This plan
complements the USDA's decision that a GM product would
not qualify for certification as "organic." Moreover, in addition
to the House's labeling bill, Senator Tom Hayden
(D-CA) recently promised to introduce legislation that would
require labeling of GM seeds, as well as GM raw and
processed food. It is possible, therefore, that mandatory labeling
will materialize by sheer momentum.
While the labeling of GM food may be a matter of time,
the manner in which this change is brought about is of
consequence. The institution of mandatory labeling forces
a paradigm shift on the FDA from product-driven regulation
to process-driven regulation, and from science-based
regulation to a regulatory system grounded in social, political,
and economic criteria. This change may well increase
the consumer confusion that labels are supposed to prevent.
As the International Dairy Foods Association
court noted, if consumer interest alone were sufficient, then there would
be no end to the information that manufacturers could be
forced to disclose on labels.
The first generation of transgenic plants had input
traits designed to affect methods and costs of production.
In contrast, the next generation of transgenic plants
contains output traits designed to alter particular properties in the
final product in response to consumer preferences. As an
example, Monsanto recently announced the development of
a new variety of rape seed plant that produces oil enriched
in beta-carotenethe compound that the human body
converts into vitamin A.
As this new generation of GM food products enters
the marketplace, it is likely that manufacturers will
voluntarily include information about their enhanced GM-based
ingredients. Of course, voluntary labeling is unlikely to
appease those anti-GM food activists who have experienced a
funding windfall created by the GM food debate.
Sources
1. Alliance for Bio-Integrity et al. v. Donna Shalala et
al., Civil Action No. 98-1300 (D.D.C., filed May 27, 1998).
2. Vogt, Donna U. and Parish, Mickey. 1999. Food
biotechnology in the United States: Science, regulation, and issues.
Congressional Research Service Report to
Congress. Available:
http://www.usia.gov/topical/global/biotech/
3. Barnett, Antony. 1999. Vatican theologians say "prudent
yes" to GM foods. The Observer, 28 November, 13.
4. International Dairy Foods Association et al. v. Amestoy
and Graves, 93 F.3d 67 (2nd Cir. 1996).
5. Seeds of Change. 1999. Consumer
Reports, September, 41-46.
Phillip B. C. Jones, PhD., J.D.
ISB News Report
The material in this News Report is compiled by NBIAP's Information Systems for Biotechnology, a joint project of USDA/CSREES and the Virginia Polytechnic Institute and State University. It does not necessarily reflect the views of the U.S. Department of Agriculture or of Virginia Tech. The News Report may be freely photocopied or otherwise distributed without charge.
Ruth Irwin, Editor (rirwin@nbiap.biochem.vt.edu)
To have the News Report automatically emailed to you, send an email message to
news@nbiap.biochem.vt.edu
and type subscribe newsreport [your_name] in the message section. Do not include a signature file or additional text.
Connect to http://www.isb.vt.edu for internet access to ISB News Reports, textfiles, and databases.
Information Systems for Biotechnology, 120 Engel Hall, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, tel: 540-231-2620, fax: 540-231-2614, email:
isb@vt.edu
GLOBAL TREATY ADOPTED ON GENETICALLY MODIFIED ORGANISMS
Convention on Biological Diversity
http://www.biodiv.org

Agricultural genomics and biotechnology risk assessment
Food safety and the role of nutrition in health
New uses for agricultural products, including biomass fuel
sources
Natural resources management, pest management, and
precision agriculture
Farm efficiency and profitability, with an emphasis on
small- and mid-sized family farms

Department of Biology and Environmental Sciences
Kingwood College
bshmaefs@nhmccd.edu
Information Systems for Biotechnology
Virginia Tech
rirwin@nbiap.biochem.vt.edu

Carnegie Institution of Washington
Department of Plant Biology
claire@Andrew2.Stanford.edu
Department of Biology and Environmental Sciences
Kingwood College
bshmaefs@nhmccd.edu
Carnegie Institution of Washington
Department of Plant Biology
claire@Andrew2.Stanford.edu
Department of Biology and Environmental Sciences
Kingwood College
bshmaefs@nhmccd.edu

Department of Animal and Poultry Sciences
Virginia Tech
ewong@vt.edu

Seattle, Washington
pbcj@wolfenet.com

120 Engel Hall
Virginia Tech
Blacksburg, VA 24061